MSP and RON (over)‐expression in breast cancer specimens correlates with poor prognosis and distant recurrence (Lee et al., 2005; Welm et al., 2007), suggesting that the MSP–RON axis contributes to disease progression. This evidence concerns the gene MST1 and breast carcinoma.